Email

weborders@prabadincorp.com

Call us

+1 (786)-332-3938
Drug Test
  • April 14, 2025

The undetected murder? Evaluation and validation of a practicable and rapid inductively coupled plasma‐mass spectrometry method for the detection of arsenic, lead, and thallium intoxications in postmortem blood

An ICP-MS method was developed using a modified acidic workup for the quantitative determination of arsenic, lead, and thallium in…
Drug Test
  • April 14, 2025

Isolation and characterization of synthesis intermediates and side products in hexahydrocannabiphorol

A commercially purchased hexahydrocannabiphorol (HHCP) sample for recreational use was analyzed by GC-MS. In addition to the declared (9R)- and…
Drug Test
  • April 14, 2025

The analysis of methylamphetamine and para‐hydroxy‐methylamphetamine in post‐mortem hair samples using liquid chromatography–tandem mass spectrometry

We present an analytical method for the determination of methylamphetamine (MA), amphetamine, and para-hydroxy-methylamphetamine (p-OH-MA) in hair. Concentrations of p-OH-MA…
fda-approves-nivolumab-with-ipilimumab-for-unresectable-or-metastatic-hepatocellular-carcinoma Drug Test
  • April 11, 2025

FDA approves nivolumab with ipilimumab for unresectable or metastatic hepatocellular carcinoma

On April 11, 2025, the Food and Drug Administration approved nivolumab (Opdivo, Bristol Myers Squibb Company) with ipilimumab (Yervoy, Bristol…
sunscreen-meetings Drug Test
  • April 11, 2025

Sunscreen Meetings

Sunscreen Meetings
Drug Test
  • April 11, 2025

Optimization of Parallel Artificial Liquid Membrane Extraction for the Determination of Over 50 Psychoactive Substances in Oral Fluid Through UHPLC–MS/MS

This study is related to the development of a microextraction method for the determination of 56 psychoactive substances in oral…
fda-announces-plan-to-phase-out-animal-testing-requirement-for-monoclonal-antibodies-and-other-drugs Drug Test
  • April 10, 2025

FDA Announces Plan to Phase Out Animal Testing Requirement for Monoclonal Antibodies and Other Drugs

FDA Announces Plan to Phase Out Animal Testing Requirement for Monoclonal Antibodies and Other Drugs
other-|-cancer-accelerated-approvals Drug Test
  • April 10, 2025

Other | Cancer Accelerated Approvals

This listing includes accelerated approvals (AAs) for malignant hematology and oncology indications that have been granted for supportive care products…
fda-listing-of-authorized-generics Drug Test
  • April 9, 2025

FDA Listing of Authorized Generics

FDA Listing of Authorized Generics
fda-approves-nivolumab-with-ipilimumab-for-unresectable-or-metastatic-msi-h-or-dmmr-colorectal-cancer Drug Test
  • April 8, 2025

FDA approves nivolumab with ipilimumab for unresectable or metastatic MSI-H or dMMR colorectal cancer

On April 8, 2025, the FDA approved nivolumab (Opdivo, Bristol Myers Squibb Company) with ipilimumab (Yervoy, Bristol Myers Squibb Company)…